Literature DB >> 14646170

Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin.

Makoto Kanda1, Kumi Satoh, Kazuo Ichihara.   

Abstract

Effects of atorvastatin and pravastatin on glucose tolerance in mildly induced diabetic rats by streptozotocin at 24 mg/kg, i.v. were studied. Non-diabetic and diabetic rats were given orally 0.5% carboxymethylcellulose (control), 8 mg/kg atorvastatin or 8 mg/kg pravastatin once a day for 6 weeks. An oral glucose tolerance test (OGTT) was carried out 1, 2, 3, and 6 weeks after the administration. The blood glucose and plasma insulin levels measured before OGTT in the diabetic rats were not different from those in the non-diabetic rats. However, the hyperglycemic response to OGTT in the diabetic rats significantly exceeded that in the non-diabetic rats. The plasma insulin increased by OGTT in the diabetic rats appeared to be lower than that in the non-diabetic rats. Statin treatments for 1 week did not modify the OGTT-induced hyperglycemia appreciably, although there were some significant differences. More than 2 weeks after administration, the blood glucose levels at several time points after a glucose intake in the atorvastatin-treated diabetic rats were significantly higher than the respective levels in the control diabetic rats. Neither atorvastatin nor pravastatin modified the OGTT-induced insulin secretion. Statins, especially atorvastatin, may influence the glucose tolerance in mildly induced diabetic rats without alterations of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646170     DOI: 10.1248/bpb.26.1681

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  22 in total

1.  Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetes.

Authors:  X Palomer; L Calpe-Berdiel; J Verdaguer; J Carrillo; X Pastor; D Mauricio; F Blanco-Vaca
Journal:  Diabetologia       Date:  2005-06-30       Impact factor: 10.122

Review 2.  Differential metabolic actions of specific statins: clinical and therapeutic considerations.

Authors:  Soo Lim; Ichiro Sakuma; Michael J Quon; Kwang Kon Koh
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 3.  Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Amirhossein Sahebkar; Renato Giua; Claudio Pedone
Journal:  Br J Clin Pharmacol       Date:  2016-10-04       Impact factor: 4.335

Review 4.  Statin use and risk of diabetes mellitus.

Authors:  Bharti Chogtu; Rahul Magazine; K L Bairy
Journal:  World J Diabetes       Date:  2015-03-15

Review 5.  Pharmacological treatment and therapeutic perspectives of metabolic syndrome.

Authors:  Soo Lim; Robert H Eckel
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

6.  Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.

Authors:  Feng Li; Mian Zhang; Dan Xu; Can Liu; Ze-Yu Zhong; Ling-Ling Jia; Meng-Yue Hu; Yang Yang; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

Review 7.  Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes.

Authors:  Anthony Paulo Sunjaya; Angela Felicia Sunjaya; Samuel Halim; Frans Ferdinal
Journal:  Int J Angiol       Date:  2016-02-18

8.  Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.

Authors:  M Regina Castro; Gyorgy Simon; Stephen S Cha; Barbara P Yawn; L Joseph Melton; Pedro J Caraballo
Journal:  J Gen Intern Med       Date:  2016-02-05       Impact factor: 5.128

9.  Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Authors:  Swapnil N Rajpathak; Dharam J Kumbhani; Jill Crandall; Nir Barzilai; Michael Alderman; Paul M Ridker
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 19.112

10.  Associations of statin use with glycaemic traits and incident type 2 diabetes.

Authors:  Fariba Ahmadizar; Carolina Ochoa-Rosales; Marija Glisic; Oscar H Franco; Taulant Muka; Bruno H Stricker
Journal:  Br J Clin Pharmacol       Date:  2019-03-18       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.